Literature DB >> 3921971

Polychlorinated biphenyl uptake and transport by lymph and plasma components.

D L Busbee, J S Yoo, J O Norman, C O Joe.   

Abstract

The uptake and vascular transport of ingested Aroclor 1242, an isomeric mixture of polychlorinated biphenyls (PCB), was investigated in experimental animals. High concentrations of ingested PCB were found in the chylomicron fraction of thoracic duct lymph. When the lymph flow was exteriorized PCB were not subsequently found in the vascular circulation. When lymph was not exteriorized plasma PCB concentrations reached maximal levels 6 hr after ingestion. Less than 1% of total plasma PCB was detected in cellular fractions of blood over a 10-hr period following ingestion. Chylomicrons contained 31% of total plasma PCB 30 min after ingestion, decreasing to less than 6% at 4 hr. A maximum of 10% of plasma PCB at 1 hr, and less than 5% at 6 hr, after ingestion was associated with very low density lipoproteins (VLDL) or low density lipoproteins (LDL). Although PCB enter the vascular circulation with the chylomicron fractions of lymph, delipoproteinated plasma contained 52% of the total PCB in blood collected 30 min after ingestion. This level increased to 78% after 2 hr, and remained constant at about 80% for an additional 8-hr period. High performance liquid chromatographic (HPLC) examinations of delipoproteinated plasma from blood taken 6 hr after PCB ingestion showed elution of greater than 95% of plasma PCB to coincide with the albumin peak. Electrophoretic examinations of delipoproteinated plasma showed the association of PCB with albumin to be noncovalent. The results suggest that apolar PCB are absorbed into intestinal epithelial cells from which they are secreted into the lymphatic drainage sequestered within the apolar core of chylomicrons, that these PCB transit the thoracic duct and enter the vascular circulation within chylomicrons and are metabolized or otherwise released from chylomicrons during hepatic chylomicron clearance, and that resulting PCB or PCB derivatives circulate in association with plasma albumins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921971     DOI: 10.3181/00379727-179-42073

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  8 in total

1.  Intestinal Lymphatic Transport: an Overlooked Pathway for Understanding Absorption of Plant Secondary Compounds in Vertebrate Herbivores.

Authors:  Kevin D Kohl; M Denise Dearing
Journal:  J Chem Ecol       Date:  2017-03-02       Impact factor: 2.626

2.  Distribution of toxaphene, DDT, and PCB among lipoprotein fractions in rat and human plasma.

Authors:  A Mohammed; A Eklund; A M Ostlund-Lindqvist; P Slanina
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 3.  Chiral polychlorinated biphenyls: absorption, metabolism and excretion--a review.

Authors:  Izabela Kania-Korwel; Hans-Joachim Lehmler
Journal:  Environ Sci Pollut Res Int       Date:  2015-02-06       Impact factor: 4.223

Review 4.  Factors affecting the storage and excretion of toxic lipophilic xenobiotics.

Authors:  R J Jandacek; P Tso
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

5.  Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration.

Authors:  Mohamad Firas Bassissi; Anne Lespine; Michel Alvinerie
Journal:  Parasitol Res       Date:  2004-08-26       Impact factor: 2.289

Review 6.  The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants.

Authors:  Zuzana Majkova; Michal Toborek; Bernhard Hennig
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

7.  Gastrointestinal uptake and vascular transport of 2,4'-dichlorobiphenyl.

Authors:  D L Busbee; R L Ziprin
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

8.  Availability of polychlorinated biphenyls (PCBs) and lindane for uptake by intestinal Caco-2 cells.

Authors:  A G Oomen; J Tolls; M Kruidenier; S S Bosgra; A J Sips; J P Groten
Journal:  Environ Health Perspect       Date:  2001-07       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.